The present study demonstrated that darolutamide significantly increases the efficacy of FINs against ferroptosis both in vivo and in vitro, indicating that this combination is a potential synergistic treatment for PCa, especially for patients with AR variants. Here, AR is linked to posterior cortical atrophy.